What is LOPJLB’s current signal on RIGL?

LOPJLB’s latest quantitative signal on Rigel Pharmaceuticals, Inc. (RIGL) is BUY in a BULL regime. Signals are updated daily.

What market regime is RIGL in?

Rigel Pharmaceuticals, Inc. (RIGL) is currently classified in the BULL HMM market regime on LOPJLB.

What does Rigel Pharmaceuticals, Inc. (RIGL) do?

Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; REZLIDHIA, a non-intensive monotherapy to treat adult patients with rel…